TET2 c.4144C>G ;(p.H1382D)

Variant ID: 4-106190866-C-G

NM_001127208.2(TET2):c.4144C>G;(p.H1382D)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease.

Leukemia
Dawoud, Ahmed A Z AAZ; Gilbert, Rodney D RD; Tapper, William J WJ; Cross, Nicholas C P NCP
Publication Date: 2022-02

Variant appearance in text: TET2: H1382D
PubMed Link: 34413458
Variant Present in the following documents:
  • 41375_2021_1382_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



TET2 missense variants in human neoplasia. A proposal of structural and functional classification.

Molecular Genetics & Genomic Medicine
Bussaglia, Elena E; Antón, Rosa R; Nomdedéu, Josep F JF; Fuentes-Prior, Pablo P
Publication Date: 2019-07

Variant appearance in text: TET2: His1382Asp
PubMed Link: 31187595
Variant Present in the following documents:
View BVdb publication page



Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.

Oncotarget
Bartels, Stephan S; Schipper, Elisa E; Hasemeier, Britta B; Kreipe, Hans H; Lehmann, Ulrich U
Publication Date: 2016-05-24

Variant appearance in text: TET2: H1382D
PubMed Link: 27029036
Variant Present in the following documents:
  • oncotarget-07-30084-s002.xlsx, sheet 3
View BVdb publication page